200 related articles for article (PubMed ID: 35884479)
1. The Evolving Role of Radioembolization in the Treatment of Neuroendocrine Liver Metastases.
Ramdhani K; Braat AJAT
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884479
[TBL] [Abstract][Full Text] [Related]
2. Liver-Directed Locoregional Therapies for Neuroendocrine Liver Metastases: Recent Advances and Management.
Criss CR; Makary MS
Curr Oncol; 2024 Apr; 31(4):2076-2091. PubMed ID: 38668057
[TBL] [Abstract][Full Text] [Related]
3. The Role of Interventional Radiology for the Treatment of Hepatic Metastases from Neuroendocrine Tumor: An Updated Review.
Barat M; Cottereau AS; Kedra A; Dermine S; Palmieri LJ; Coriat R; Dautry R; Tselikas L; Soyer P; Dohan A
J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32698459
[TBL] [Abstract][Full Text] [Related]
4. Surgical management of pancreatic neuroendocrine liver metastases.
Cloyd JM; Wiseman JT; Pawlik TM
J Gastrointest Oncol; 2020 Jun; 11(3):590-600. PubMed ID: 32655938
[TBL] [Abstract][Full Text] [Related]
5. Transarterial Chemoembolization vs Radioembolization for Neuroendocrine Liver Metastases: A Multi-Institutional Analysis.
Egger ME; Armstrong E; Martin RC; Scoggins CR; Philips P; Shah M; Konda B; Dillhoff M; Pawlik TM; Cloyd JM
J Am Coll Surg; 2020 Apr; 230(4):363-370. PubMed ID: 32032719
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine tumor liver metastases treated with yttrium-90 radioembolization.
Fan KY; Wild AT; Halappa VG; Kumar R; Ellsworth S; Ziegler M; Garg T; Rosati LM; Su Z; Hacker-Prietz A; Pawlik TM; Cosgrove DP; Hong KK; Kamel IR; Geschwind JF; Herman JM
Contemp Clin Trials; 2016 Sep; 50():143-9. PubMed ID: 27520932
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine liver metastases: a contemporary review of treatment strategies.
Cloyd JM; Ejaz A; Konda B; Makary MS; Pawlik TM
Hepatobiliary Surg Nutr; 2020 Aug; 9(4):440-451. PubMed ID: 32832495
[TBL] [Abstract][Full Text] [Related]
8. Phase 1b study of pasireotide, everolimus, and selective internal radioembolization therapy for unresectable neuroendocrine tumors with hepatic metastases.
Kim HS; Shaib WL; Zhang C; Nagaraju GP; Wu C; Alese OB; Chen Z; Brutcher E; Renfroe M; El-Rayes BF
Cancer; 2018 May; 124(9):1992-2000. PubMed ID: 29451701
[TBL] [Abstract][Full Text] [Related]
9. Radioembolization with
Braat AJAT; Kappadath SC; Ahmadzadehfar H; Stothers CL; Frilling A; Deroose CM; Flamen P; Brown DB; Sze DY; Mahvash A; Lam MGEH
Cardiovasc Intervent Radiol; 2019 Mar; 42(3):413-425. PubMed ID: 30603975
[TBL] [Abstract][Full Text] [Related]
10. Currently available treatment options for neuroendocrine liver metastases.
Machairas N; Daskalakis K; Felekouras E; Alexandraki KI; Kaltsas G; Sotiropoulos GC
Ann Gastroenterol; 2021; 34(2):130-141. PubMed ID: 33654350
[TBL] [Abstract][Full Text] [Related]
11. Arterial Therapies of Non-Colorectal Liver Metastases.
Puippe G; Pfammatter T; Schaefer N
Viszeralmedizin; 2015 Dec; 31(6):414-22. PubMed ID: 26889145
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes following 90Y Radioembolization of neuroendocrine liver metastases: evaluation of the radiation-emitting SIR-spheres in non-resectable liver tumor (RESiN) registry.
Wong TY; Zhang KS; Gandhi RT; Collins ZS; O'Hara R; Wang EA; Vaheesan K; Matsuoka L; Sze DY; Kennedy AS; Brown DB
BMC Cancer; 2022 Mar; 22(1):224. PubMed ID: 35232410
[TBL] [Abstract][Full Text] [Related]
13. Radioembolization with
Braat AJAT; Ahmadzadehfar H; Kappadath SC; Stothers CL; Frilling A; Deroose CM; Flamen P; Brown DB; Sze DY; Mahvash A; Lam MGEH
Cardiovasc Intervent Radiol; 2020 Feb; 43(2):246-253. PubMed ID: 31646375
[TBL] [Abstract][Full Text] [Related]
14. Local therapies for hepatic metastases.
Johnston FM; Mavros MN; Herman JM; Pawlik TM
J Natl Compr Canc Netw; 2013 Feb; 11(2):153-60. PubMed ID: 23411382
[TBL] [Abstract][Full Text] [Related]
15. Surgery, Liver Directed Therapy and Peptide Receptor Radionuclide Therapy for Pancreatic Neuroendocrine Tumor Liver Metastases.
Ngongoni R; Visser B
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291892
[TBL] [Abstract][Full Text] [Related]
16. Intra-arterial liver-directed therapies for neuroendocrine hepatic metastases.
Gupta S
Semin Intervent Radiol; 2013 Mar; 30(1):28-38. PubMed ID: 24436515
[TBL] [Abstract][Full Text] [Related]
17. Yttrium-90 radioembolization of isolated hepatic adrenocortical carcinoma metastases with negative surgical pathology.
Lu S; Dhillon J; Johnson JH; El-Haddad G
EJNMMI Res; 2021 Feb; 11(1):17. PubMed ID: 33604708
[TBL] [Abstract][Full Text] [Related]
18. Non-Pharmacological Therapeutic Options for Liver Metastases in Advanced Neuroendocrine Tumors.
Dermine S; Palmieri LJ; Lavolé J; Barré A; Dohan A; Abou Ali E; Cottereau AS; Gaujoux S; Brezault C; Chaussade S; Coriat R
J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31703375
[TBL] [Abstract][Full Text] [Related]
19. Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review.
Harring TR; Nguyen NT; Goss JA; O'Mahony CA
Int J Hepatol; 2011; 2011():154541. PubMed ID: 22013537
[TBL] [Abstract][Full Text] [Related]
20. Radioembolization and chemoembolization for unresectable neuroendocrine liver metastases - a systematic review.
Yang TX; Chua TC; Morris DL
Surg Oncol; 2012 Dec; 21(4):299-308. PubMed ID: 22846894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
